{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:22Z","timestamp":1761518782903,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000},"content-version":"vor","delay-in-days":3352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ejvs.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T10:16:12Z","timestamp":1107857772000},"page":"403-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Secondary Prevention of Atherosclerosis Through Chlamydia pneumoniae Eradication (SPACE Trial): A Randomised Clinical Trial in Patients with Peripheral Arterial Disease"],"prefix":"10.1016","volume":"29","author":[{"given":"T.","family":"Vainas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.R.M.","family":"Stassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.W.H.","family":"Schurink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.M.","family":"Tordoir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.Th.J.","family":"Welten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.H.J.M.","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.J.M.","family":"Kurvers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.E.H.M.","family":"Kitslaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2005.01.001_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease [see comments]","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jama.1921.02630110008002","article-title":"Arteriosclerosis and cardiovascular disease: their relation to infectious diseases","volume":"76","author":"Ophuls","year":"1921","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2005.01.001_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archinte.1911.00060080033004","article-title":"The relationship between acute infectious diseases and arterial lesions","volume":"8","author":"Frothingham","year":"1911","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejvs.2005.01.001_bib4","series-title":"Modern medicine: its practice and theory","first-page":"429","article-title":"Diseases of the arteries","author":"Osler","year":"1908"},{"key":"10.1016\/j.ejvs.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1084\/jem.148.1.335","article-title":"Virus-induced atherosclerosis","volume":"148","author":"Fabricant","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejvs.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0002-9149(84)90016-X","article-title":"Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients","volume":"53","author":"Spodick","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2005.01.001_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0002-8703(81)90150-2","article-title":"Acute myocardial infarction precipitated by infectious disease","volume":"101","author":"Pesonen","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejvs.2005.01.001_bib8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(88)90741-6","article-title":"Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction","volume":"2","author":"Saikku","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2005.01.001_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/infdis\/167.4.841","article-title":"Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries","volume":"167","author":"Kuo","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejvs.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(97)07201-2","article-title":"Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group [see comments]","volume":"350","author":"Gurfinkel","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.CIR.96.2.404","article-title":"Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction","volume":"96","author":"Gupta","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.102.15.1755","article-title":"Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study","volume":"102","author":"Muhlestein","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib13","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jama.290.11.1459","article-title":"Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial","volume":"290","author":"O'Connor","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.CIR.0000054613.57105.06","article-title":"for the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte (Working Group of Leading Hospital Cardiologists; ALKK). Antibiotic therapy after acute myocardial infarction: a prospective randomized study","volume":"107","author":"Zahn","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-9150(03)00204-1","article-title":"High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study","volume":"172","author":"Diehm","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/AAC.37.11.2318","article-title":"Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus","volume":"37","author":"Meyer","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejvs.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003495-199651030-00013","article-title":"Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections","volume":"51","author":"Dunn","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.ejvs.2005.01.001_bib18","first-page":"2","article-title":"Recommendations guiding physicians in biomedical research involving human subjects","volume":"35","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejvs.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0950-821X(05)80676-0","article-title":"The fate of the claudicant\u2014a prospective study of 1969 claudicants","volume":"5","author":"Dormandy","year":"1991","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.ejvs.2005.01.001_bib20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(97)22010-6","article-title":"Dead is dead\u2014artificial definitions are no substitute","volume":"349","author":"Gottliep","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1034\/j.1600-0463.2003.1110210.x","article-title":"Chlamydia pneumoniae serology: comparing a commercial enzyme immunoassay and microimmunofluorescence test in patients with cardiovascular disease","volume":"111","author":"Vainas","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.ejvs.2005.01.001_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/322632","article-title":"Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)","volume":"33","author":"Dowell","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejvs.2005.01.001_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.STR.0000014508.65367.8F","article-title":"Chlamydia pneumoniae serology is associated with thrombosis-related but not with plaque-related microembolization during carotid endarterectomy","volume":"33","author":"Vainas","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2005.01.001_bib24","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.103.10.1390","article-title":"Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity","volume":"103","author":"Sander","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/01.CIR.100.8.832","article-title":"Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis","volume":"100","author":"Markus","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(03)12706-7","article-title":"Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the azithromycin in acute coronary syndrome (AZACS) trial: a randomised controlled trial","volume":"361","author":"Cercek","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2005.01.001_bib27","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/01.CIR.0000017862.08503.15","article-title":"Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial","volume":"105","author":"Wiesli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.CIR.0000027820.66786.CF","article-title":"Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames trial of antibiotics in myocardial infarction and unstable angina (STAMINA)","volume":"106","author":"Stone","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/01.CIR.0000012544.07696.1F","article-title":"Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome","volume":"105","author":"Sinisalo","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib30","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(00)05181-3","article-title":"Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial","volume":"357","author":"Neumann","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2005.01.001_bib31","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/01.CIR.0000117232.30832.EC","article-title":"Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity","volume":"109","author":"Sander","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/euhj.1998.1283","article-title":"Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study [see comments]","volume":"20","author":"Gurfinkel","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2005.01.001_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/41.1.85","article-title":"The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production","volume":"41","author":"Sinisalo","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejvs.2005.01.001_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0002-9149(02)03417-3","article-title":"Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function","volume":"91","author":"Kuvin","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2005.01.001_bib35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/hc1102.105649","article-title":"Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection","volume":"105","author":"Parchure","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mva.2001.117891","article-title":"Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study","volume":"34","author":"Mosorin","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2005.01.001_bib37","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1046\/j.0007-1323.2001.01845.x","article-title":"Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion","volume":"88","author":"Vammen","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2005.01.001_bib38","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1161\/01.STR.0000038098.04291.F6","article-title":"Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques","volume":"33","author":"Axisa","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2005.01.001_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/ejvs.1999.0915","article-title":"Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study","volume":"18","author":"Melissano","year":"1999","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2005.01.001_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00168-2","article-title":"Evidence for infectious agents in cardiovascular disease and atherosclerosis","volume":"2","author":"Leinonen","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ejvs.2005.01.001_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0021-9150(01)00761-4","article-title":"Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women","volume":"163","author":"Bloemenkamp","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2005.01.001_bib42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/44.3.411","article-title":"Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease [in process citation]","volume":"44","author":"Jackson","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejvs.2005.01.001_bib43","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/AAC.42.10.2762","article-title":"In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries","volume":"42","author":"Gieffers","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejvs.2005.01.001_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/AAC.46.2.409-412.2002","article-title":"Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection model","volume":"46","author":"Kutlin","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejvs.2005.01.001_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.103.3.351","article-title":"Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment","volume":"103","author":"Gieffers","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/bmj.313.7054.428c","article-title":"Relation of C reactive protein to cardiovascular risk factors. H. pylori and C. pneumoniae infections may account for most acute coronary syndromes","volume":"313","author":"Aceti","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2005.01.001_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0140-6736(87)90888-9","article-title":"High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis","volume":"2","author":"Adam","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2005.01.001_bib48","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.CIR.102.19.2335","article-title":"Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the cardiovascular health study [in process citation]","volume":"102","author":"Siscovick","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2005.01.001_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/hc0102.101362","article-title":"Impact of infectious burden on extent and long-term prognosis of atherosclerosis","volume":"105","author":"Espinola-Klein","year":"2002","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.1016\/j.ejvs.2005.01.001_bib50","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1086\/315596","article-title":"Background and current knowledge of Chlamydia pneumoniae and atherosclerosis","volume":"181","author":"Grayston","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejvs.2005.01.001_bib51","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1161\/01.CIR.96.11.4095","article-title":"Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research","volume":"96","author":"Libby","year":"1997","journal-title":"Circulation"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858840500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858840500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:36:28Z","timestamp":1761042988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107858840500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S107858840500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2005.01.001","relation":{},"ISSN":["1078-5884"],"issn-type":[{"type":"print","value":"1078-5884"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary Prevention of Atherosclerosis Through Chlamydia pneumoniae Eradication (SPACE Trial): A Randomised Clinical Trial in Patients with Peripheral Arterial Disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2005.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}